STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #223 by analyst upside · 2026-06-27
HIND
Vyome Holdings, Inc.
Healthcare · Market Cap $15M · P/E 0x
ANALYST PRICE TARGET
+432.4%
implied upside to consensus target
Current Price $2.16
Consensus Target $11.5
Bull Target $15.0
Bear Target $8.0
Analysts Covering 2
ANALYST CONSENSUS — STRONG BUY
Strong Buy
2
Buy
0
Hold
0
Sell
0
52-Week Low $1.75
52-Week High $18.6
YTD Return -39.2%
FUNDAMENTALS
Market Cap $15M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-1.59
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $0M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $1.75
52-Week High $18.6
Current Price $2.16
Bear Target $8.0
Bull Target $15.0
● Now $2.16 ● Target $11.5
TRADING DATA
Avg Volume 27K
YTD Return -39.2%
Analyst Count 2
Consensus Strong Buy
Upside to Target +432.4%
Last Updated 2026-06-27

ANALYST SUMMARY

Vyome Holdings, Inc. (HIND) is currently trading at $2.16 with a Wall Street consensus price target of $11.5, implying potential upside of 432.4% over the next 12 months. 2 analysts currently cover HIND, with a consensus rating of Strong Buy — 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $15.0, while the most cautious has a target of $8.0.

HIND operates in the Healthcare sector with a market capitalisation of $15M. The stock is down 39.2% year-to-date and is currently trading near the lower end of its 52-week range of $1.75 – $18.6.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →